Nav: Home

How family and friends influence breast cancer treatment decisions

June 28, 2017

ANN ARBOR, Michigan -- When a woman walks into the oncologist's office, she's usually not alone. In fact, a new study finds that half of women have at least three people standing behind them, sitting next to them or waiting at home to help.

In most cases, these support people are going with the patient to appointments, taking notes, finding additional resources and helping talk through treatment options.

"People just diagnosed with cancer are often scared and overwhelmed. Having another person to help them process information is important," says Lauren P. Wallner, Ph.D., MPH, assistant professor of general medicine and epidemiology at the University of Michigan. Wallner is the lead author of the paper, published in the journal Cancer.

"Physicians need to recognize that women involve other people in their treatment decisions. These people represent an important group to provide information about treatment options," Wallner notes.

The study surveyed 2,502 women with early stage breast cancer about two months after they had surgery. Women were asked to list specific individuals who were involved in helping them make a treatment decision.

Half of the respondents listed at least three people and 20 percent listed two people. Only 10 percent said they had no personal decision support network. Nearly three-quarters of women said their support network talked with them about their treatment options and frequently attended their appointments.

African-American and Latina women reported larger networks than white women. Women who were married or partnered also reported more support.

Even among women without a partner or spouse, many had large support networks. Women reported children, friends, siblings, parents and other relatives were involved in their decision-making.

"Minority women tend to have larger networks, so clinicians should also be aware that there could be differences in the number of people patients might be involving. And these networks go beyond just a partner or spouse," Wallner says.

Larger support networks were associated with more deliberation about treatment, which the researchers suggest could be critical as treatment options become more complex. More deliberation suggests patients are thinking through pros and cons, discussing it with others and weighing the decision carefully.

"When patients are diagnosed with cancer, there's this rush to get through the treatment process. But for patients with early stage breast cancer, they have some time to decide on their treatment choice," Wallner says.

"The idea that women are discussing their options more with their family and friends and potentially thinking through that decision more carefully is reassuring. Engaging these informal support networks could be a way to prevent women from rushing into something," she says.

The researchers recommend physicians incorporate family and friends into the conversation, delivering information and decision aids to everyone in the room, as well as providing information that can be shared with those back at home.

Typically, decision aids and other materials are written for the patient. Wallner says this study suggests the need to broaden these materials to include family and friends who play a role in helping a woman understand her treatment choices.

"When considering these complex treatment options and going through these complex decisions, it's beneficial to have the support of other people. This helps women feel supported in their decisions," Wallner says.

At the same time, women without a support network may need extra help or information during the decision process, Wallner points out.

"It starts with something as simple as physicians asking patients who is helping them make their treatment decisions. That can then guide the conversation, such as the amount of resources the physician provides and to whom they communicate that information," she says.
-end-
Additional authors: Yun Li, Ph.D.; M. Chandler McLeod, Ph.D., M.S.; Ann S. Hamilton, Ph.D.; Kevin C. Ward, Ph.D.; Christine M. Veenstra, M.D., MSHP; Lawrence C. An, M.D.; Nancy K. Janz, Ph.D.; Steven J. Katz, M.D.; Sarah T. Hawley, Ph.D.

Funding: National Cancer Institute grant P01CA163233, American Cancer Society grant RSG-14-035-01

Disclosure: None

Reference: Cancer, doi: 10.1002/cncr.30848, published online June 22, 2017

Resources:

University of Michigan Comprehensive Cancer Center, http://www.mcancer.org

Michigan Medicine Cancer AnswerLine, 800-865-1125

Michigan Health Lab, http://www.MichiganHealthLab.org

Michigan Medicine - University of Michigan

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

An Announcement from Radiolab